The estimated Net Worth of Christopher C. Miskel is at least $1.5 million dollars as of 9 May 2024. Mr. Miskel owns over 1,840 units of Arthur J. Gallagher & Co stock worth over $1,500,063 and over the last 5 years he sold AJG stock worth over $0. In addition, he makes $0 as Independent Director at Arthur J. Gallagher & Co.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Miskel AJG stock SEC Form 4 insiders trading
Christopher has made over 4 trades of the Arthur J. Gallagher & Co stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 1,840 units of AJG stock worth $542,156 on 9 May 2024.
The largest trade he's ever made was exercising 3,720 units of Arthur J. Gallagher & Co stock on 11 May 2021 worth over $1,096,098. On average, Christopher trades about 584 units every 64 days since 2020. As of 9 May 2024 he still owns at least 5,091 units of Arthur J. Gallagher & Co stock.
You can see the complete history of Mr. Miskel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Miskel biography
Christopher Miskel serves as Independent Director of the Company. Since 2017, Mr. Miskel has served as President and Chief Executive Officer of Versiti, Inc., one of the largest independent blood products supply companies in the United States. From 2013 to 2017, Mr. Miskel served in senior management roles at Baxter International Inc., a publicly traded healthcare company, Baxalta Incorporated, which spun off from Baxter in July 2015, and Shire plc, which acquired Baxalta in June 2016. During this period, Mr. Miskel served as Vice President, U.S. BioScience National Accounts from 2013 to 2014, as Vice President, Plasma Strategy and New Product Development from 2014 to 2015, and as Head – Global Immunology from 2015 to 2017. Prior to 2013, he served in roles of increasing responsibility at Eli Lilly and Company, a publicly traded healthcare company. His tenure at Lilly included management experience in Australia and New Zealand. Mr. Miskel also currently serves as a member of the Medical College of Wisconsin Board of Trustees, the Board of Directors of the Milwaukee Regional Medical Center, and on the Executive Committee of the Board of Blood Centers of America. Mr. Miskel’s qualifications to serve on our Board include his senior executive experience, his involvement in setting strategy for large businesses such as Lilly, Baxter, Baxalta and Shire, his extensive sales and marketing experience, and his knowledge of the healthcare industry and related privacy and cybersecurity issues.
How old is Christopher Miskel?
Christopher Miskel is 45, he's been the Independent Director of Arthur J. Gallagher & Co since 2020. There are 26 older and no younger executives at Arthur J. Gallagher & Co. The oldest executive at Arthur J. Gallagher & Co. is William Bax, 76, who is the Independent Director.
What's Christopher Miskel's mailing address?
Christopher's mailing address filed with the SEC is 2850 GOLF ROAD, , ROLLING MEADOWS, IL, 60008.
Insiders trading at Arthur J. Gallagher & Co
Over the last 21 years, insiders at Arthur J. Gallagher & Co have traded over $68,753,154 worth of Arthur J. Gallagher & Co stock and bought 72,268 units worth $2,773,086 . The most active insiders traders include J Patrick Jr Gallagher, Douglas K Howell et Thomas Joseph Gallagher. On average, Arthur J. Gallagher & Co executives and independent directors trade stock every 9 days with the average trade being worth of $3,869,344. The most recent stock trade was executed by Thomas Joseph Gallagher on 8 August 2024, trading 15,000 units of AJG stock currently worth $1,061,100.
What does Arthur J. Gallagher & Co do?
gallagher, a global insurance brokerage and risk management services firm, helps clients address risk, protect assets and recover from losses. the products and services we provide keep businesses and institutions running, and enable individuals and families to rebuild their lives. gallagher is the only insurance broker recognized by the ethisphere institute as a world's most ethical company. gallagher provides retail and wholesale property and casualty brokerage, alternative risk transfer services, employee benefit consulting, and actuarial services. gallagher also offers claims and information management, risk control consulting and appraisal services, human resource consulting, and retirement services. find us on social media: facebook: http://www.facebook.com/lifeatgallagher instagram: http://instagram.com/lifeatgallagher twitter: https://twitter.com/lifeatgallagher or http://twitter.com/ajgcorporate
What does Arthur J. Gallagher & Co's logo look like?
Complete history of Mr. Miskel stock trades at Arthur J. Gallagher & Co
Arthur J. Gallagher & Co executives and stock owners
Arthur J. Gallagher & Co executives and other stock owners filed with the SEC include:
-
J. Patrick Gallagher,
Chairman of the Board, Chief Executive Officer -
J. Patrick Gallagher Jr.,
Chairman, Pres & CEO -
Douglas Howell,
Chief Financial Officer, Corporate Vice President -
Thomas Gallagher,
Corporate Vice President, Chairman - International Brokerage Operation, President- Retail Property/Casualty Brokerage Operation -
Walter Bay,
Corporate Vice President, General Counsel, Secretary -
Scott Hudson,
Corporate Vice President, President - Risk Management Operation -
Douglas K. Howell,
Corp. VP & CFO -
Thomas Joseph Gallagher,
Corp. VP and Pres of Global Property & Casualty Brokerage Operation -
Scott R. Hudson,
Corp. VP & Pres of Risk Management Operation -
Walter D. Bay,
Corp. VP, Gen. Counsel & Sec. -
David Johnson,
Lead Independent Director -
William Bax,
Independent Director -
Sherry Barrat,
Independent Director -
Kay McCurdy,
Independent Director -
Norman Rosenthal,
Independent Director -
Ralph Nicoletti,
Independent Director -
Frank English,
Independent Director -
David Coldman,
Independent Director -
Raymond Iardella,
Vice President, Investor Relations -
Christopher Miskel,
Independent Director -
Susan Pietrucha,
Corporate Vice President, Chief Human Resource Officer -
Joel Cavaness,
Corporate Vice President, President - Wholesale Brokerage Operation -
Christopher Mead,
Chief Marketing Officer, Corporate Vice President -
Richard Cary,
Chief Accounting Officer, Controller -
William Ziebell,
Corporate Vice President and President -
Richard C. Cary,
Chief Accounting Officer & Controller -
Linda J. Collins,
VP of Corp. Communications -
Sean P. Connelly,
Global Chief Information Officer and Corp. VP -
David R. Long,
VP -
Elbert O Hand,
Director -
James W Jr Durkin,
Vice President -
Ilene S Gordon,
Director -
James R Wimmer,
Director -
David E Jr Mcgurn,
Vice President -
T Kimball Brooker,
Director -
Richard J Mckenna,
Vice President -
Gary P/Pa Coughlan,
Director -
John C Rosengren,
Vice President, General -
Elizabeth Brinkerhoff,
Vice President -
Nicholas M Elsberg,
Vice President -
Bernard L Hengesbaugh,
Director -
James J Iii Braniff,
Vice President -
James S Gault,
President -
Robert E Gallagher,
Chairman -
Patrick Murphy Gallagher,
Chief Operating Officer -
Vishal Jain,
VICE PRESIDENT -
Mark H. Bloom,
Vice President -
Teresa Hillary Clarke,
Director -
Deborah H Caplan,
Director -
Richard De Winton Wilkin Ha...,
Director